During the past decade, Zhejiang Provincial People's Hospital/Dermatology Department conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Zhejiang Provincial People's Hospital/Dermatology Department" are "Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis" (1 trials), "Eczema" (1 trials) and "Genetic Diseases, Inborn" (1 trials). Many other conditions were trialed in "Zhejiang Provincial People's Hospital/Dermatology Department" in a lesser frequency.

Most popular intervention types in "Zhejiang Provincial People's Hospital/Dermatology Department" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Crisaborole Ointment" (1 trials) and "Crisaborole Placebo Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zhejiang Provincial People's Hospital/Dermatology Department" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Zhejiang Provincial People's Hospital/Dermatology Department". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Zhejiang Provincial People's Hospital/Dermatology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhejiang Provincial People's Hospital/Dermatology Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".